|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Gamete Biology |
Department of Urologic Surgery,3
the Department of Genetics, Cell Biology, and Development,4 University of Minnesota, Minneapolis, Minnesota 55455
| ABSTRACT |
|---|
|
|
|---|
acrosome reaction, epididymis, gamete biology, sperm capacitation, sperm maturation
| INTRODUCTION |
|---|
|
|
|---|
Under normal conditions, ejaculated sperm are unable to fertilize an egg until they have resided in the female tract for a number of hours (the time varies among species [25, 26]) and have undergone capacitation. Capacitation was independently and virtually simultaneously described by two laboratory groups [27, 28] as the time required for sperm to penetrate an egg after having been deposited in the female reproductive tract. Residence in the female tract is required for capacitation in vivo, resulting in the acquisition of hyperactivated motility in many but not all species [1], the loss of or changes in some constituents of the plasma membrane, including proteins and glycoproteins [2932], and the acquisition of the ability to undergo the acrosome reaction [1].
During the more than half-century since its discovery, capacitation has been the subject of intense investigation (for reviews, see [3336]), particularly because it is possible to capacitate sperm in vitro and use them to fertilize an egg. Common themes concerning the process of capacitation are beginning to emerge. In all species that have been examined, cholesterol must be removed from the membrane, which can be accomplished in vitro by incubating sperm in a medium containing serum albumin [37, 38] or other cholesterol-binding agents such as cyclodextrins [39, 40]. Cholesterol removal results in cAMP-dependent tyrosine phosphorylation of a number of proteins, both in the sperm plasma membrane and in intracellular structures such as the axoneme and fibrous sheath [35]. Initiation and completion of capacitation is absolutely dependent on extracellular Ca2+ and HCO3- and a cholesterol-sequestering agent [41].
We conducted experiments to elucidate the conditions and outcomes of in vitro capacitation of rat spermatozoa and to determine the effects of Crisp-1 on capacitation. Like all spermatozoa studied so far, in rat spermatozoa phosphorylation of tyrosine residues on numerous proteins occurs during 5 h of in vitro incubation under controlled conditions. Tyrosine phosphorylation is dependent upon cAMP, HCO3-, and Ca2+ and on the removal of cholesterol from the membrane. Crisp-1, which was added to the sperm surface in the epididymis in vivo, is lost during capacitation; addition of exogenous Crisp-1 to the incubation medium inhibits tyrosine phosphorylation in a dose-dependent manner and thus inhibits capacitation.
| MATERIALS AND METHODS |
|---|
|
|
|---|
Anti-phosphotyrosine (4G10) monoclonal IgG conjugated to horseradish peroxidase (HRP) was purchased from Upstate Biotechnology (Lake Placid, NY). Alexa Fluor 488 goat anti-rabbit IgG, Amplex Red Cholesterol Assay Kit, and Slow-Fade were purchased from Molecular Probes (Eugene, OR). Cold-water fish skin gelatin (40% solution) was purchased from Electron Microscopy Sciences (Washington, PA). Super Signal West Pico Chemiluminescent Substrate was purchased from Pierce Chemical Co. (Rockford, IL). ALBUMAX I lipid-rich BSA was purchased from Gibco BRL (Grand Island, NY). Original and modified BWW solutions were purchased from Irvine Scientific (Santa Ana, CA). All other chemicals and reagents were purchased from Sigma-Aldrich (St. Louis, MO). Generation of the CAP-A anti-peptide polyclonal antibody and the 4E9 monoclonal antibody has been previously described [3, 6].
Media
The base medium used for collection and experimental incubation of sperm was original formula BWW [42]. BWW minus calcium or bicarbonate was prepared according to the recipe reported by Biggers et. al. [42]. Sperm were capacitated in BWW with 15 mg/ml ALBUMAX I lipid-rich BSA unless otherwise noted. Other cholesterol acceptor molecules included fraction V BSA and methyl-ß-cyclodextrin and were added to BWW in some experiments.
Sperm Collection and Preparation
Spague-Dawley retired male breeder rats were killed by CO2 asphyxiation, and epididymides were surgically removed. Radial slits were made in each of the cauda epididymides followed by a 5-min incubation in 1 ml of BWW buffered with 21 mM Hepes on an orbital shaker to facilitate the swim-out of sperm into the medium. The sperm suspensions were placed in a 1.5-ml microcentrifuge tube, leaving behind the epididymides, and gently shaken by hand to ensure an even concentration of sperm. Sperm counts were performed using a hemacytometer. Aliquots of approximately 3.5 x 106 sperm were diluted into 0.5 ml of capacitation medium that was pre-equilibrated overnight at 37°C in 5% CO2. The incubation wells were overlaid with 0.5 ml of mineral oil and incubated for various times (see figure captions) at 37°C in 5% CO2. Subjective assessment of sperm motility showed minimal decreases during capacitation incubation. All animal experiments were approved by the Institutional Animal Care and Use Committee of the University of Minnesota.
SDS-PAGE and Western Blotting
Samples were prepared for SDS-PAGE analysis using a modification of the protocol described by Visconti et al. [43]. Sperm were collected from under oil and centrifuged at 16 000 x g in microcentrifuge tubes for 5 min immediately following the capacitation incubation. The sperm pellet was washed twice with 1 ml of PBS and resuspended in 100 µl of 1x Laemmli sample buffer [44]. The samples were vortexed for 15 sec, heated to 95°C for 5 min, and centrifuged at 16 000 x g to remove insoluble material. Supernatants were transferred to new tubes, reduced by the addition of ß-mercaptoethanol (to a final concentration of 2.5%), and heated again to 95°C for 5 min. PAGE with 20 µl of each sample, equivalent to 7 x 105 sperm, was performed with Tris-glycine gels (7.5%, 12%, or 15%, depending on the experiment). Proteins were transferred to Immobilon P membranes (Millipore, Bedford, MA) at 100 volts for 1 h at 4°C.
For detection of tyrosine-phosphorylated proteins, blots were blocked with 6.5% fish skin gelatin in Tris-buffererd saline with 0.1% Tween 20 (TBS-T) for 30 min followed by incubation with anti-phosphotyrosine-HRP antibody (1:15 000) in blocking solution for 1 h at room temperature. The blots were washed with TBS-T, followed by incubation with HRP substrate (Super Signal West Pico) for 5 min. Blots were exposed to x-ray film for 5l30 sec. Western blot detection of the protein D and protein E forms of Crisp-1 with anti-peptide antibody CAP-A and monoclonal antibody 4E9 were done as previously described [3, 6].
Immunocytochemistry
Sperm were stained immunocytochemically with anti-peptide antibody CAP-A and monoclonal antibody 4E9 essentially as previously described [3]. Sperm were washed three times in BWW to remove medium, fixed with Bouin fixative for 30 min, and washed extensively with PBS. Cells were blocked for 30 min with 1% BSA/PBS, and antibodies were added for 1 h of incubation at room temperature. The anti-peptide antibody CAP-A was used at a dilution of 1:200, and monoclonal antibody 4E9 was used at dilution of 1:1000. Sperm were then washed another three times with PBS. Alexa-Fluor 488 anti-rabbit antibody was added to the CAP-A tubes, and anti-mouse fluorescein isothiocyanate was added to the 4E9 tubes. After incubation for 1 h in Alexa-Fluor second antibody at room temperature, cells were washed with PBS, mounted on slides in Slow-Fade, and viewed using a fluorescent microscope (Nikon, Tokyo, Japan).
Cholesterol Assay
Total lipids were extracted from BWW containing the cholesterol-binding molecule methyl-ß-cyclodextran (MBCD) after incubation with sperm essentially as described by Bligh and Dyer [45]. After incubating sperm with BWW/MBCD, sperm were removed by centrifugation, and 0.8 ml of supernatant was recovered. Chloroform and methanol were added to the supernatant to a final ratio of chloroform:methanol:aqueous supernatant of 2:2:1.8. After vigorous vortexing, the final mixture was centrifuged for 5 min at 600 x g, and 1 ml of the organic (lower) phase was removed to a new tube. The lipids in the organic phase were dried under a stream of desiccated nitrogen and stored at -20°C.
Cholesterol was measured in the extracted lipid samples using the Amplex Red Cholesterol Assay Kit, according to the manufacturer's instructions. Dried lipid samples were resuspended in 50 µl of reaction buffer and mixed 1:1 with a working solution containing 300 µM Amplex Red reagent, 2 U/ml HRP, 2 U/ml cholesterol oxidase, and 2 U/ml cholesterol esterase in wells of a 96-well microtiter plate. A standard curve was prepared using the cholesterol reference standard provided with the kit. All samples were incubated for 2 h at 37°C. Fluorescence of reaction product was measured at various time points in a FL600 Microplate Reader (Biotek Instruments, Winooski, VT) with an excitation filter of 530 nm and an emission filter of 590 nm.
Acrosome Reaction and Staining
The acrosome reaction and assessment of acrosomal status was performed essentially as described by Bendahmane et al. [46]. Following incubation under capacitating or noncapacitating conditions for 30 min, progesterone (P4), dissolved in dimethyl sulfoxide, was added to a final concentration of 1 µM. After an additional 30 min of incubation, sperm were fixed in 4% paraformaldehyde, washed, and dried on slides. To visualize the acrosome, the sperm were stained with 0.22% Coomassie blue G-250 solution for 2 min, rinsed with distilled water, and allowed to air dry. Slides were coverslipped using Permount mounting medium and observed under a Nikon brightfield microscope at a magnification of 600x. For each condition within an experiment, 500 cells were assessed for acrosomal status.
Statistical Analysis
All experiments were repeated a minimum of three times. Raw data from the acrosome reaction experiments were subjected to the Tukey analysis for determination of significant differences (P < 0.05) between pairs of treatment groups.
| RESULTS |
|---|
|
|
|---|
|
Initial capacitation experiments were carried out in a solution of 15 mg/ml lipid-rich BSA, a concentration of BSA routinely used in our BWW solution for in vitro fertilization. Because most capacitation experiments are conducted using fraction V BSA, we compared the efficacy of using lipid-rich or fraction V BSA at various concentrations. Lipid-rich BSA was superior to fraction V for inducing tyrosine phosphorylation in rat sperm at all concentrations investigated (Fig. 2A). Incubation of sperm with fraction V BSA produced very low levels of tyrosine phosphorylation in rat sperm. When the same comparison was performed using mouse sperm, where fraction V BSA is routinely used, the efficacy of tyrosine phosphorylation was the same (Fig. 2B). These results suggest that different BSA preparations have different effects on sperm depending on the species. The basis for this variation is not clear.
|
The dependence of rat sperm capacitation on exogenous Ca2+ is shown in Figure 3. Incubation for 4 h without exogenously added Ca2+ resulted in minimal tyrosine phosphorylation compared with sperm incubated with 1.7 mM Ca2+. The level of tyrosine phosphorylation in the absence of exogenous Ca2+ was higher than that seen in the absence of BSA, which may be attributable to trace amounts of Ca2+ in the medium or to the availability of Ca2+ from intracellular sources. Likewise, capacitation was dependent on the presence of bicarbonate ion in the medium, as determined by assessing protein tyrosine phosphorylation in the presence and absence of HCO3- (Fig. 4). Solutions in this experiment were buffered with Hepes buffer to insure that the results were not affected by the buffering capacity of the medium.
|
|
To examine the relationship between cholesterol removal from the sperm plasma membrane and the protein tyrosine phosphorylation events associated with capacitation, sperm were incubated with two doses of the cholesterol-binding molecule MBCD. During incubation with MBCD, cholesterol was removed from the sperm in a dose-dependent fashion. MBCD at 2 mM removed twice as much cholesterol as 1 mM MBCD (Fig. 5A). When protein tyrosine phosphorylation was measured, phosphorylation in 2 mM MBCD was higher in both kinetics and total amount than that observed with 1 mM MBCD (Fig. 5B). Protein tyrosine phosphorylation lagged behind the removal of cholesterol from the sperm plasma membrane, as indicated by the fact that cholesterol removal was at a plateau within 30 min with 1 mM MBCD (Fig. 5A) yet no increase in phosphorylation was observed until 2 h (Fig. 5B). These results indicated that protein tyrosine phosphorylation is dependent on cholesterol removal in a dose-dependent fashion but that the kinetics of cholesterol removal is not rate limiting for the phosphorylation process.
|
The removal of cholesterol from cell membranes affects the organization of lipid microdomains (rafts), which in turn can affect signaling events in the cell [47]. To determine whether the removal of cholesterol from rat epididymal sperm is associated with changes in lipid rafts, sperm were stained with the ß subunit of cholera toxin (ßCT), which binds to the ganglioside GM1 (a lipid present in many lipid rafts) before and after cholesterol removal. Immediately after isolation of sperm from the rat epididymis, specific staining with ßCT was visible over the equatorial segment and the head cap region (Fig. 6). This staining pattern remained constant after 5 h of incubation in BWW without the cholesterol-binding molecule. However, after 5 h of incubation with 15 mg/ml BSA or 1 mM MBCD, ßCT staining became diffuse over the entire sperm head and became visible on the sperm tail. Virtually all of the sperm observed (>99%) underwent this redistribution. This result indicates that lipid rafts on sperm are disrupted by removal of cholesterol, and raft components such as GM1 are redistributed on the surface of the sperm. This redistribution is correlated with sperm capacitation, implicating raft-associated signaling events in the capacitation process.
|
Crisp-1 is a sperm maturation protein secreted in two forms, proteins D and E [6, 48, 49], by the epididymal epithelium, and both forms become bound to the sperm surface during epididymal transit [3, 50]. The majority of Crisp-1 is lost from sperm during incubation after ejaculation or after incubation of sperm isolated from the epididymis [51]. Antibodies that differentiate between the binding of protein D and that of protein E were used to demonstrate that the majority of the protein D form of Crisp-1 is lost during capacitation incubation, with or without a cholesterol binding agent (Fig. 7). However, the protein E form of Crisp-1 remains confined to the tail of the sperm without detectable loss or redistribution during the capacitation process.
|
Because the loss of the protein D form of Crisp-1 occurs during the time frame of sperm capacitation, presence of exogenous Crisp-1 may inhibit the capacitation process. Figure 8A shows the effect on protein tyrosine phosphorylation of incubating sperm under capacitating conditions in the presence of increasing concentrations of purified Crisp-1. At a dose of 400 µg/ml, Crisp-1 almost completely inhibited the protein tyrosine phosphorylation associated with capacitation. Reprobing of these Western blots with anti-peptide antibody CAP-A, which recognizes all forms of Crisp-1, revealed that the endogenous D form of Crisp-1 (protein D, 32 kDa) is lost from the sperm during capacitation and that exogenous protein D becomes associated with the sperm coincident with the inhibition of capacitation (Fig. 8B). When this Western blot was probed with monoclonal antibody 4E9, which recognizes only the E form of Crisp-1 (protein E,
28 kDa), the blot showed that protein E is not lost from the sperm surface during capacitation and no additional protein E associates with sperm during the incubation with exogenous Crisp-1 (Fig. 8C).
|
The protein E form of Crisp-1 is processed as it associates with sperm in the epididymis, and a portion of the protein D form of Crisp-1 may also be processed as it associates with sperm [6]. Comparison of Figures 8B and 8C reveals the presence of a processed form of Crisp-1 that is not recognized by the 4E9 antibody. Thus, the processed forms of Crisp-1 attach permanently to the sperm, and the unprocessed form of protein D interacts dynamically with the sperm plasma membrane to reversibly prevent capacitation-associated tyrosine phosphorylation.
If the tyrosine phosphorylation events suppressed by Crisp-1 represent the suppression of capacitation, then Crisp-1 should also be able to inhibit the ability of the cells to undergo an induced acrosome reaction. To explore this possibility, rat sperm were capacitated for 1 h with 15 mg/ml BSA in the presence or absence of 400 µg/ml Crisp-1, and the acrosome reaction was induced with 1 µM progesterone (P4). There was a significant increase in the acrosome reaction in capacitated sperm after incubation with P4 (P < 0.05) (Fig. 9). This increase was completely suppressed (P < 0.05) by addition of exogenous Crisp-1. This result indicates that Crisp-1 inhibits capacitation in rat sperm.
|
The dynamic nature of the interaction between Crisp-1 (unprocessed form) and the sperm surface suggests that the inhibition of protein tyrosine phosphorylation by Crisp-1 may be reversible. To explore this possibility, sperm were incubated under capacitating conditions in the presence of 200 µg/ml Crisp-1 for 5 h and then removed to capacitation medium devoid of Crisp-1. Significant suppression by Crisp-1 of protein tyrosine phosphorylation was observed after 5 h of incubation (Fig. 10A). After 3 additional hours of incubation in the absence of Crisp-1, protein tyrosine phosphoryation had resumed and continued to 24 h. The resumption of phosphorylation activity was correlated with the loss of Crisp-1 from the sperm (Fig. 10B).
|
Previous studies on the requirements for capacitation in mouse sperm have shown that Ca2+, HCO3-, and removal of cholesterol from the sperm plasma membrane are all required for the protein tyrosine phosphorylation events of capacitation [41]. However, the absence of any of these three could be compensated for by the addition of cAMP analogs, demonstrating that cAMP signaling in the sperm is intermediary to protein tyrosine phosphorylation [43]. A similar signaling pathway exists for rat sperm. When sperm were incubated in the presence of the cAMP analog dibromo-cAMP (db-cAMP) and the phosphodiesterase inhibitor IBMX, protein tyrosine phosphorylation occurred in the absence of any of the three molecules required for capacitation (Fig. 11A). Stimulation of the cAMP pathway by db-cAMP and IBMX also overcame the inhibition of capacitation caused by exogenous Crisp-1 (Fig. 11B). These results indicate that the signaling pathway leading to capacitation is similar for the mouse and the rat and that Crisp-1 inhibits capacitation by intervening in an event upstream from the stimulation of cAMP production by the sperm.
|
| DISCUSSION |
|---|
|
|
|---|
Sperm of most if not all mammals require cholesterol removal from the plasma membrane for capacitation to occur. However, the mechanism by which cholesterol removal facilitates capacitation in sperm is not known. One likely possibility is that removal of cholesterol from lipid rafts facilitates the movement of signaling molecules in the plasma membrane, allowing critical interactions that lead to the activation of adenylate cyclase and subsequent tyrosine phosphorylation of target proteins. Several recent studies have provided evidence for the existence of lipid rafts on mouse and guinea pig sperm [5355]. We demonstrated in this study that rat sperm contain discrete regions of staining for binding of ßCT, which binds to the ganglioside GM1, a common lipid component of membrane rafts. Furthermore, the discrete localization of GM1 is lost during cholesterol extraction with either BSA or MBCD, suggesting that molecules within the sperm plasma membrane begin to diffuse upon removal of cholesterol. A similar diffusion of lipids in the sperm plasma membrane has been reported in boar sperm during in vitro capacitation [56].
The degree of tyrosine phosphorylation in rat sperm is dependent upon the extent of cholesterol extraction. Doubling of the amount of MBCD used to extract cholesterol from the sperm membrane increased the maximal degree of tyrosine phosphorylation at the 5 h time point (Fig. 5). Increasing MBCD also increased the kinetics of phosphorylation. These findings suggest that if liberation of signaling molecules to move in the plasma membrane is the mechanism by which cholesterol extraction works, removing more cholesterol facilitates more interactions and with faster kinetics. However, removal of cholesterol under the conditions of our experiments is not rate limiting for subsequent tyrosine phosphorylation. Using 1 mM MBCD, extraction of cholesterol reached a plateau within 30 min, but an increase in tyrosine phosphorylation was not detected until 2 h and was not maximal until 3 h. The delay between cholesterol removal and tyrosine phosphorylation is consistent with a requirement for physical redistribution of signaling molecules within the plasma membrane.
The requirement for bicarbonate ion in rat sperm capacitation is consistent with a role for the bicarbonate-dependent soluble adenylate cyclase that has been implicated in the capacitation process in sperm from other mammalian species [5759]. In a previous study using boar sperm, when bicarbonate ion was left out of the medium, cholesterol was not lost from the plasma membrane during incubation in the presence of BSA [59]. The authors of that study proposed that the role of bicarbonate ion was to activate the bicarbonate-dependent adenylate cyclase, which in turn caused the cAMP-dependent activation of flipase, which is required for cholesterol removal from the plasma membrane. In the work presented here, the absence of bicarbonate was overcome by addition of cAMP analog and IBMX, consistent with a capacitation requirement for cAMP downstream of the requirement for bicarbonate ion. However, cholesterol removal from the membrane proceeded normally in the absence of bicarbonate ion, supporting a mechanism of capacitation where cAMP acts downstream of cholesterol removal from the membrane (data not shown).
Both capacitation and the acrosome reaction are calcium ion-dependent functions of mammalian sperm [35, 36]. Our results demonstrate that exogenous calcium is required for the tyrosine phosphorylation accompanying capacitation, consistent with this requirement shown in previous studies of other mammal species [41, 60]. The specific calcium-dependent molecular events of capacitation have not been identified, but the ability to use exogenous cAMP analogs to overcome the absence of calcium in the medium suggests that the calcium-dependent events in the sperm are upstream of the activation of adenylate cyclase.
In addition to the requirement for Ca2+, HCO3-, and a cholesterol-binding agent in capacitation, we also demonstrated a requirement for the disassociation of Crisp-1 from the sperm membrane for capacitation to proceed in rat sperm. Immunocytochemistry results revealed that a portion of the Crisp-1 staining is lost from the sperm with incubation, primarily from the head region (Fig. 7), and Western blot analysis revealed that the 32-kDa form of Crisp-1 is lost from the sperm membrane (Fig. 8). The addition of exogenous Crisp-1 inhibits protein tyrosine phosphorylation in a reversible manner, suggesting that Crisp-1 interacts with a specific protein or lipid on the sperm surface in a dynamic ligand-receptor fashion and inhibits the capacitation process. Given this effect of Crisp-1 on rat sperm capacitation and the high concentration of Crisp-1 in epididymal fluid, it is likely that Crisp-1 acts as a capacitation inhibiting factor.
Crisp-1 also inhibited the P4-induced acrosome reaction, supporting the hypothesis that Crisp-1 inhibits capacitation and that protein tyrosine phosphorylation is required for capacitation in the rat. The level of induced acrosome reaction was low compared with that seen in other species but was consistent with that in a previous report on rat sperm [46]. The very high percentage of spontaneous acrosome reactions that occur in rat sperm with time during capacitation, >75% by 3 h (data not shown), makes it difficult to measure the induced acrosome reaction at extended time points, where phosphorylation is more easily measured.
The mechanism by which Crisp-1 inhibits the progression of rat sperm to capacitation is unknown. However, potential mechanisms of action can be inferred from similarities between this protein and other proteins of known function. The primary amino acid sequence of Crisp-1 is highly similar to that of many toxins, in particular helothermine produced by the lizard Heloderma horridum [61]. Helothermine acts as an inhibitor of calcium flux through the ryanodine receptor, a regulated calcium channel in muscle cells [61]. Because calcium is required for capacitation, Crisp-1 may prevent the uptake of needed calcium via channels in the sperm plasma membrane. Ryanodine receptors have been reported in testicular germ cells and sperm, but their exact localization remains unclear [62, 63]. However, Crisp-1 may act on the sperm by interacting with a ryanodine receptor or a ryanodine receptor-like channel in the sperm plasma membrane. It remains to be determined whether Crisp-1 inhibits Ca2+ uptake by the sperm and, if so, what molecule(s) it interacts with to achieve such inhibition.
Crisp-1 is the only known secretory protein of the epididymis to possess capacitation inhibitory activity. However, proteins or factors in secretions of the male reproductive tract with apparent capacitation inhibitory activity have been reported for several species [16, 6467]. The mouse seminal vesicle autoantigen inhibits protein tyrosine phosphorylation associated with sperm capacitation, and human seminal plasma contains a factor(s) with similar activity [16, 67]. Although little is known of the mechanism of capacitation suppression reported in seminal plasma and secretory proteins of the seminal vesicles, suppression of premature capacitation appears to be an important function of fluids of the male excurrent reproductive tract.
In addition to the 32-kDa form of Crisp-1 that interacts in a reversible way with the sperm plasma membrane to inhibit capacitation, a second smaller form is also found on sperm; this form is strongly attached and is not removed during incubation under capacitating conditions. Both the D and E forms of Crisp-1 are processed [6]. The processed E form of Crisp-1 is recognized by monoclonal antibody 4E9 and localizes to the sperm tail; its function there is unknown [6].
Crisp-1 has been implicated as playing a role in sperm-egg fusion. Results from a number of studies in rat, mouse, and human systems have shown that fusion of sperm to the plasma membrane of zona pellucida-free eggs is inhibited in the presence of Crisp-1 [6870]. Preincubation of zona pellucida-free eggs with Crisp-1, followed by immunocytochemistry with an antibody specific to Crisp-1, demonstrated specific binding sites for Crisp-1 on the surface of eggs [68]. These findings suggest that Crisp-1 can inhibit sperm-egg fusion and are consistent with the hypothesis that Crisp-1 is involved in sperm-egg fusion. However, there are no known fusogenic domains contained within the amino acid sequence of Crisp-1, and nothing in the predicted tertiary structure of the protein suggests a role in membrane fusion. Therefore, it is unlikely that Crisp-1 mediates the sperm-egg fusion event directly. Given the ability of Crisp-1 to block the signaling cascade leading to capacitation, a possible role for Crisp-1 in sperm-egg fusion may involve regulation of signaling events, particularly those associated with protein tyrosine phosphorylation. Processed Crisp-1 remaining on the sperm plasma membrane could interact with signaling molecules on the egg surface to initiate or otherwise regulate the fusion event.
| ACKNOWLEDGMENTS |
|---|
| FOOTNOTES |
|---|
2 Correspondence: David W. Hamilton, Department of Genetics, Cell Biology, and Development, University of Minnesota, 420 Johnston Hall, 101 Pleasant St. SE, Minneapolis, MN 55455. FAX: 612 626 7431; dwh{at}umn.edu ![]()
Received: 3 December 2002.
First decision: 22 December 2002.
Accepted: 17 March 2003.
| REFERENCES |
|---|
|
|
|---|
This article has been cited by other articles:
![]() |
G. M. Gibbs, K. Roelants, and M. K. O'Bryan The CAP Superfamily: Cysteine-Rich Secretory Proteins, Antigen 5, and Pathogenesis-Related 1 Proteins--Roles in Reproduction, Cancer, and Immune Defense Endocr. Rev., December 1, 2008; 29(7): 865 - 897. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. P. Roberts, K. M. Ensrud-Bowlin, L. B. Piehl, K. R. Parent, M. L. Bernhardt, and D. W. Hamilton Association of the Protein D and Protein E Forms of Rat CRISP1 with Epididymal Sperm Biol Reprod, December 1, 2008; 79(6): 1046 - 1053. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. L. Vadnais, D. N. Foster, and K. P. Roberts Molecular Cloning and Expression of the CRISP Family of Proteins in the Boar Biol Reprod, December 1, 2008; 79(6): 1129 - 1134. [Abstract] [Full Text] [PDF] |
||||
![]() |
|